U.S. Advisers Say ‘No’ to Routine PSA Tests for Prostate Cancer

MONDAY, May 21 (HealthDay News) — In a highly anticipated move sure to unleash heated debate, a prominent U.S. government advisory panel is recommending that men of all ages no longer be screened for prostate cancer by undergoing the prostate-specific antigen (PSA) blood test.